Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies

Nancy M. Heddle, Richard J. Cook, Kathryn E. Webert, Christopher Sigouin, Paolo Rebulla

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

BACKGROUND: Prophylactic platelet transfusions are given to thrombocytopenic patients to prevent bleeding. The benefit of platelet transfusions has frequently been assessed by measuring the count increment; however, more recently, an assessment of bleeding has been used because it is a more clinically relevant outcome measure. The purpose of this study was to identify platelet transfusion trigger studies that used bleeding as an outcome measure, compare and contrast methods used to document bleeding and analyze bleeding outcomes, and identify and discuss methodologic issues to consider when bleeding is used as a study outcome. STUDY DESIGN AND METHODS: A systematic search to identify platelet transfusion trigger studies was performed. Relevant articles were reviewed to identify how bleeding data was captured and analyzed, and methodologic considerations were identified. RESULTS: Seven articles meeting the predefined entry criteria were identified. Methods used to document bleeding included chart review and clinical assessment. The frequency of assessment and the type of personnel performing the assessment were variable. Four approaches to analysis were identified: descriptive; comparison of the proportions of patients having at least one bleed; comparison of patient days with bleeding expressed as a proportion of the total days at risk of bleeding; and time-to-event (first bleed) analysis. CONCLUSION: Methodologic issues for consideration when designing a clinical study with bleeding as the outcome measure included approaches to minimize bias in the documentation and classification of bleeding and selection of an analysis approach that is appropriate to the question being asked. The need for development of a valid and reliable bleeding scale was also identified.

Original languageEnglish
Pages (from-to)742-752
Number of pages11
JournalTransfusion
Volume43
Issue number6
DOIs
Publication statusPublished - Jun 1 2003

Fingerprint

Transfusion Medicine
Hemorrhage
Platelet Transfusion
Outcome Assessment (Health Care)
Documentation

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. / Heddle, Nancy M.; Cook, Richard J.; Webert, Kathryn E.; Sigouin, Christopher; Rebulla, Paolo.

In: Transfusion, Vol. 43, No. 6, 01.06.2003, p. 742-752.

Research output: Contribution to journalArticle

Heddle, Nancy M. ; Cook, Richard J. ; Webert, Kathryn E. ; Sigouin, Christopher ; Rebulla, Paolo. / Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. In: Transfusion. 2003 ; Vol. 43, No. 6. pp. 742-752.
@article{6fd65bd76ab54ce4a24951fa684d56a1,
title = "Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies",
abstract = "BACKGROUND: Prophylactic platelet transfusions are given to thrombocytopenic patients to prevent bleeding. The benefit of platelet transfusions has frequently been assessed by measuring the count increment; however, more recently, an assessment of bleeding has been used because it is a more clinically relevant outcome measure. The purpose of this study was to identify platelet transfusion trigger studies that used bleeding as an outcome measure, compare and contrast methods used to document bleeding and analyze bleeding outcomes, and identify and discuss methodologic issues to consider when bleeding is used as a study outcome. STUDY DESIGN AND METHODS: A systematic search to identify platelet transfusion trigger studies was performed. Relevant articles were reviewed to identify how bleeding data was captured and analyzed, and methodologic considerations were identified. RESULTS: Seven articles meeting the predefined entry criteria were identified. Methods used to document bleeding included chart review and clinical assessment. The frequency of assessment and the type of personnel performing the assessment were variable. Four approaches to analysis were identified: descriptive; comparison of the proportions of patients having at least one bleed; comparison of patient days with bleeding expressed as a proportion of the total days at risk of bleeding; and time-to-event (first bleed) analysis. CONCLUSION: Methodologic issues for consideration when designing a clinical study with bleeding as the outcome measure included approaches to minimize bias in the documentation and classification of bleeding and selection of an analysis approach that is appropriate to the question being asked. The need for development of a valid and reliable bleeding scale was also identified.",
author = "Heddle, {Nancy M.} and Cook, {Richard J.} and Webert, {Kathryn E.} and Christopher Sigouin and Paolo Rebulla",
year = "2003",
month = "6",
day = "1",
doi = "10.1046/j.1537-2995.2003.00418.x",
language = "English",
volume = "43",
pages = "742--752",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Blackwell Publishing Inc.",
number = "6",

}

TY - JOUR

T1 - Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies

AU - Heddle, Nancy M.

AU - Cook, Richard J.

AU - Webert, Kathryn E.

AU - Sigouin, Christopher

AU - Rebulla, Paolo

PY - 2003/6/1

Y1 - 2003/6/1

N2 - BACKGROUND: Prophylactic platelet transfusions are given to thrombocytopenic patients to prevent bleeding. The benefit of platelet transfusions has frequently been assessed by measuring the count increment; however, more recently, an assessment of bleeding has been used because it is a more clinically relevant outcome measure. The purpose of this study was to identify platelet transfusion trigger studies that used bleeding as an outcome measure, compare and contrast methods used to document bleeding and analyze bleeding outcomes, and identify and discuss methodologic issues to consider when bleeding is used as a study outcome. STUDY DESIGN AND METHODS: A systematic search to identify platelet transfusion trigger studies was performed. Relevant articles were reviewed to identify how bleeding data was captured and analyzed, and methodologic considerations were identified. RESULTS: Seven articles meeting the predefined entry criteria were identified. Methods used to document bleeding included chart review and clinical assessment. The frequency of assessment and the type of personnel performing the assessment were variable. Four approaches to analysis were identified: descriptive; comparison of the proportions of patients having at least one bleed; comparison of patient days with bleeding expressed as a proportion of the total days at risk of bleeding; and time-to-event (first bleed) analysis. CONCLUSION: Methodologic issues for consideration when designing a clinical study with bleeding as the outcome measure included approaches to minimize bias in the documentation and classification of bleeding and selection of an analysis approach that is appropriate to the question being asked. The need for development of a valid and reliable bleeding scale was also identified.

AB - BACKGROUND: Prophylactic platelet transfusions are given to thrombocytopenic patients to prevent bleeding. The benefit of platelet transfusions has frequently been assessed by measuring the count increment; however, more recently, an assessment of bleeding has been used because it is a more clinically relevant outcome measure. The purpose of this study was to identify platelet transfusion trigger studies that used bleeding as an outcome measure, compare and contrast methods used to document bleeding and analyze bleeding outcomes, and identify and discuss methodologic issues to consider when bleeding is used as a study outcome. STUDY DESIGN AND METHODS: A systematic search to identify platelet transfusion trigger studies was performed. Relevant articles were reviewed to identify how bleeding data was captured and analyzed, and methodologic considerations were identified. RESULTS: Seven articles meeting the predefined entry criteria were identified. Methods used to document bleeding included chart review and clinical assessment. The frequency of assessment and the type of personnel performing the assessment were variable. Four approaches to analysis were identified: descriptive; comparison of the proportions of patients having at least one bleed; comparison of patient days with bleeding expressed as a proportion of the total days at risk of bleeding; and time-to-event (first bleed) analysis. CONCLUSION: Methodologic issues for consideration when designing a clinical study with bleeding as the outcome measure included approaches to minimize bias in the documentation and classification of bleeding and selection of an analysis approach that is appropriate to the question being asked. The need for development of a valid and reliable bleeding scale was also identified.

UR - http://www.scopus.com/inward/record.url?scp=0038350664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038350664&partnerID=8YFLogxK

U2 - 10.1046/j.1537-2995.2003.00418.x

DO - 10.1046/j.1537-2995.2003.00418.x

M3 - Article

C2 - 12757525

AN - SCOPUS:0038350664

VL - 43

SP - 742

EP - 752

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 6

ER -